Hypothalamic-pituitary-adrenal axis and monoamine transmitter activity in depression: A pilot study of central and peripheral effects of electroconvulsive therapy

[1]  H. Akil,et al.  Neuropeptide Concentrations in the Cerebrospinal Fluid of Depressed Patients Treated with Electroconvulsive Therapy , 1991, British Journal of Psychiatry.

[2]  H. Sackeim,et al.  Acute and subacute effects of ECT on plasma HVA, MHPG, and prolactin , 1989, Biological Psychiatry.

[3]  F. Goodwin,et al.  Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) , 1988, The New England journal of medicine.

[4]  C. Nemeroff,et al.  Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients. , 1988, Journal of affective disorders.

[5]  C. Nemeroff.  The Role of Corticotropin-Releasing Factor in the Pathogenesis of Major Depression , 1988, Pharmacopsychiatry.

[6]  J. Eagles,et al.  Selective effects of ECT on hypothalamic—pituitary activity , 1987, Psychological Medicine.

[7]  R. Anton.  Urinary free cortisol in psychotic depression , 1987, Biological Psychiatry.

[8]  J. Calabrese,et al.  Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. , 1986, The New England journal of medicine.

[9]  J. Copas,et al.  Electrophysiological and Hormonal Responses to Three Types of Electroconvulsive Therapy , 1985, British Journal of Psychiatry.

[10]  M. Scheinin,et al.  Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites. , 1985, Archives of general psychiatry.

[11]  W. Potter,et al.  Exaggerated orthostatic responsivity of plasma norepinephrine in depression. , 1985, Archives of general psychiatry.

[12]  S. Cooper,et al.  Adrenergic Receptors in Depression , 1985, British Journal of Psychiatry.

[13]  R. Kathol.  Persistent eleation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients , 1985 .

[14]  C. Kilts,et al.  Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. , 1984, Science.

[15]  M. Scheinin,et al.  Liquid chromatographic assay for CSF catecholamines using electrochemical detection. , 1984, Acta pharmacologica et toxicologica.

[16]  J. Bartko,et al.  Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients. , 1983, Archives of general psychiatry.

[17]  M. Scheinin,et al.  Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection. , 1983, Analytical biochemistry.

[18]  I. Kopin,et al.  Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. , 1983, Science.

[19]  Mortyn T. Jones,et al.  NEUROTRANSMITTER REGULATION OF CORTICOTROPIN‐RELEASING FACTOR IN VITRO , 1977, Annals of the New York Academy of Sciences.

[20]  F. Goodwin,et al.  Effect of diet on urinary MHPG excretion in depressed patients and normal control subjects. , 1977, The American journal of psychiatry.

[21]  H. Ruder,et al.  A radioimmunoassay for cortisol in plasma and urine. , 1972, The Journal of clinical endocrinology and metabolism.

[22]  M. Demitrack,et al.  Stress-responsive neurohormonal systems and the symptom complex of affective illness. , 1989, Psychopharmacology bulletin.

[23]  J. Hsiao,et al.  Disparate Biochemical Actions of Electroconvulsive Therapy and Antidepressant Drugs. , 1988, Convulsive therapy.

[24]  C. Nemeroff,et al.  CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. , 1987, The American journal of psychiatry.

[25]  S. Paul,et al.  CSF corticotropin-releasing hormone in depressed patients and normal control subjects. , 1987, The American journal of psychiatry.

[26]  H. Meltzer,et al.  Psychopharmacology : the third generation of progress , 1987 .

[27]  L. Bertilsson,et al.  Electroconvulsive Therapy Effects on Cerebrospinal Fluid Monoamine Metabolites and Platelet Serotonin Uptake In Melancholia. , 1986, Convulsive therapy.

[28]  M. Scheinin,et al.  Effects of electroconvulsive treatment on monoamine metabolites, growth hormone, and prolactin in plasma. , 1984, Biological psychiatry.